Glycerol-3-phosphate acyltransferases and metabolic syndrome: recent advances and future perspectives

Triglycerol-3-phosphate acyltransferases (GPATs) are the key enzymes in the first step of the synthesis of triacylglycerol (TAG). In mammals, there are four isoforms of GPATs. GPAT1 and GPAT2 are localised in the outer mitochondrial membrane, while GPAT3 and GPAT4 are localised in the endoplasmic re...

Full description

Saved in:
Bibliographic Details
Published inExpert reviews in molecular medicine Vol. 24; p. e30
Main Authors Huang, Yinqiong, Hu, Keyue, Lin, Shu, Lin, Xiahong
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 05.09.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Triglycerol-3-phosphate acyltransferases (GPATs) are the key enzymes in the first step of the synthesis of triacylglycerol (TAG). In mammals, there are four isoforms of GPATs. GPAT1 and GPAT2 are localised in the outer mitochondrial membrane, while GPAT3 and GPAT4 are localised in the endoplasmic reticulum. Previous research has emphasised that GPAT plays a critical effect on the development of metabolic syndromes, such as liver steatosis, obesity, and insulin resistance. In this review, we will critically evaluate the regulatory effects of GPATs isoforms in metabolic syndrome. In addition, we also discuss perspectives on clinical intervention strategies for the neurometabolic disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1462-3994
1462-3994
DOI:10.1017/erm.2022.23